Get the Weekly Intelligence Brief — top committee picks every Sunday.
GH · NASDAQ · STOCK

Guardant Health, Inc.

Healthcare Updated August 11, 2026
$165.06
52W $53.40 – $176.58
61/100
$22.15B
-47.3
1.59
AI Committee Verdict
Buy
61/100
Conviction: Contested · 75% agreement · 4 analysts
Contested

Is GH Bullish or Bearish?

Bullish. Innellis AI committee rates Guardant Health, Inc. (GH) Buy with a composite score of 61/100 , based on 4 analysts with 75% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +14.23 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -5.77 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 20.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Bollinger bandwidth of 20.0% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
61/100
Agreement
75%
Analysts
4
Conviction
Contested
Sector Rank
Top 42%
of 192 Healthcare peers
Technical Analyst bullish
69 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 20.0% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
60.9
Neutral
MACD Histogram
0.832
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.81
Inside Bands
Price vs Moving Averages
EMA 9
$161.44 Above
EMA 21
$156.93 Above
EMA 50
$145.91 Above
EMA 200
$111.95 Above

Fundamental Analysis

Valuation
67
Profitability
50
Financial Health
100
Cash Flow
15
Valuation
P/E Ratio -47.3×
P/B Ratio -97.83×
PEG Ratio 10.72
Dividend Yield 0.00%
52W High $176.58
52W Low $53.40
Quality & Growth
ROE 41918.2%
ROA -2067.3%
Gross Margin 6501.2%
Operating Margin -3974.8%
Revenue Growth YoY
Debt / Equity -7.61
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -47.3 (inexpensive relative to a 15-40x range); Price-to-book of -97.8x; PEG ratio of 10.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 419.2%; Return on assets of -20.7%; Net margin of -38.3%; Gross margin of 65.0%; Current ratio of 4.03 (healthy short-term liquidity); Debt-to-equity of -7.61; Free cash flow per share is negative (-1.82); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full GH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore GH Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime